力生制药(002393) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was CNY 434,462,480.17, representing a 10.32% increase compared to CNY 393,833,564.95 in the same period last year[9] - Net profit attributable to shareholders was CNY 44,426,621.86, an increase of 8.55% from CNY 40,928,973.44 year-on-year[9] - Total operating revenue for Q1 2019 was CNY 434,462,480.17, an increase of 10.4% compared to CNY 393,833,564.95 in Q1 2018[36] - Net profit for Q1 2019 reached CNY 44,426,621.86, representing a 8.8% increase from CNY 40,928,973.44 in Q1 2018[37] - The company's operating revenue for Q1 2019 was CNY 229,169,150.50, an increase of 13.76% compared to CNY 201,543,131.67 in the same period last year[39] - The net profit for Q1 2019 reached CNY 46,079,578.90, representing a growth of 6.52% from CNY 43,280,236.35 in Q1 2018[40] - The total comprehensive income for Q1 2019 was CNY 46,079,578.90, compared to CNY 43,280,236.35 in the previous year[40] Cash Flow and Expenses - The net cash flow from operating activities decreased by 21.18% to CNY 50,535,196.57, down from CNY 64,111,547.66 in the previous year[9] - Cash paid for operating activities amounted to CNY 177,496,547.09, an increase of 95.31% compared to the same period last year, primarily due to increased sales expenses[18] - The cash flow from operating activities generated a net amount of CNY 50,535,196.57, down from CNY 64,111,547.66 in Q1 2018[43] - The company incurred sales expenses of CNY 53,909,527.99, which is an increase of 42.73% from CNY 37,741,864.54 in Q1 2018[39] - Cash outflow from investment activities was $3.38 million, a decrease from $658.92 million in the previous period, indicating a reduction of 99.5%[45] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 5,566,394,844.80, a 42.10% increase from CNY 3,917,201,547.49 at the end of the previous year[9] - Total liabilities as of March 31, 2019, were CNY 950,900,447.81, compared to CNY 704,846,235.46 at the end of the previous year[28] - Current assets totaled CNY 2,360,041,257.83 as of March 31, 2019, compared to CNY 2,302,027,950.38 at the end of the previous year[27] - The company's total assets were reported at CNY 5,514,452,258.90, reflecting a growth of CNY 1,597,250,711.41[50] - Total liabilities amounted to CNY 944,494,064.59, with non-current liabilities at CNY 259,701,168.78[50] Shareholder Information - The net assets attributable to shareholders increased by 43.68% to CNY 4,615,494,396.99 from CNY 3,212,355,312.03[9] - The company had a total of 21,621 common shareholders at the end of the reporting period[13] - Total equity attributable to shareholders reached CNY 4,569,958,194.31, showing an increase of CNY 1,357,602,882.28 compared to the previous period[50] Earnings and Returns - Basic earnings per share rose to CNY 0.24, reflecting a 9.09% increase from CNY 0.22 in the same period last year[9] - The weighted average return on equity decreased to 0.97%, down from 1.32% year-on-year, a decline of 0.35%[9] - Basic and diluted earnings per share increased to CNY 0.25, up from CNY 0.24 in the previous year[40] Investment and Other Income - Investment income for the period increased by 187.97% to CNY 2,408,205.77, attributed to the increased net profit of Tianbian Company[17] - Other comprehensive income as of March 31, 2019, was CNY 1,363,072,737.09, an increase of 26,793.70% from the end of the previous year, due to remeasurement and reclassification under new standards[18]